Medicamentsen-ligne vous propose les traitements dont vous avez besoin afin de prendre soin de votre santé sexuelle. Avec plus de 7 ans d'expérience et plus de 80.000 clients francophones, nous étions la première clinique fournissant du acheter viagra original en France à vente en ligne et le premier vendeur en ligne de Cialis dans le monde. Pourquoi prendre des risques si vous pouvez être sûr avec Medicamentsen-ligne - Le service auquel vous pouvez faire confiance.

Mouse models of autism spectrum disorders: the challenge for behavioral genetics

American Journal of Medical Genetics Part C (Semin. Med. Genet.) 142C:40 – 51 (2006) Mouse Models of Autism Spectrum Disorders:The Challenge for Behavioral Genetics SHERYL S. MOY,* JESSICA J. NADLER, TERRY R. MAGNUSON, AND JACQUELINE N. CRAWLEY Autism is a severe neurodevelopmental disorder, which typically emerges early in childhood. The core symptomsof autism include deficits in social interaction, impaired communication, and aberrant repetitive behavior,including self-injury. Despite the strong genetic component for the disease, most cases of autism have not beenlinked to mutations in a specific gene, and the etiology of the disorder has yet to be established. At the presenttime, there is no generally accepted therapeutic strategy to treat the core symptoms of autism, and there remainsa critical need for appropriate animal models and relevant behavioral assays to promote the understanding andtreatment of the clinical syndrome. Challenges for the development of valid mouse models include complexgenetic interactions underlying the high heritability of the disease in humans, diagnosis based on deficits in socialinteraction and communication, and the lack of confirmatory neuropathological markers to provide validation forgenetic models of the disorder. Research focusing on genes that mediate social behavior in mice may help identifyneural circuitry essential for normal social interaction, and lead to novel genetic animal models of the autismbehavioral phenotype.
KEY WORDS: autism; fragile X; mice; repetitive behavior; Rett syndrome; social interaction and communication deficits, rather than a aberrations characteristic of human clin- ed in an animal. In addition, the ASDs are cellular function, and therapeutic efficacy munication, as well as aberrant repetitive ical and theoretical issues in their beha- children demonstrate rigid adherenceto routines and restricted interests, oftenforming obsessional preoccupations with Sheryl S. Moy, Ph.D., is the Associate Director of the Mouse Behavioral Phenotyping Laboratory of the Neurodevelopmental Disorders Research Center, and an Associate Professor in the Department of Psychiatry at UNC. Dr. Moy’s work focuses on the development of mouse models ic responses, such as tic-like stereotypies relevant to human clinical disorders, including autism and schizophrenia.
Jessica J. Nadler, Ph.D., is a Postdoctoral Fellow in the Department of Genetics at UNC.
Dr. Nadler works on identifying the underlying gene expression changes associated with deficits Terry R. Magnuson, Ph.D., is the Chair of the UNC Department of Genetics and Director of the Carolina Center for Genome Sciences.
Jacqueline N. Crawley, Ph.D., is Director of the Laboratory of Behavioral Neuroscience at NIMH and the Mouse Behavioral Phenotyping Laboratory of the Neurodevelopmental Disorders Research Center at UNC. Modeling neuropsychiatric disorders using mouse behavioral geneticsrepresents a theme of Dr. Crawley’s research program.
Grant sponsor: STAART; Grant number: U54 MH66418; Grant sponsor: MRDDRC; Grant number: P30 HD03110; Grant sponsor: NIMH Intramural Research Program.
*Correspondence to: Sheryl S. Moy, Neurodevelopmental Disorders Research Center, CB no.
7146, University of North Carolina, Chapel Hill, NC 27599-7146. E-mail: disorders [Gillberg and Billstedt, 2000].
AMERICAN JOURNAL OF MEDICAL GENETICS PART C (SEMIN. MED. GENET.): DOI 10.1002/ajmg.c autistic subjects may have various altera- ing susceptibility in a non-deterministic tions in brain size and neuroanatomy.
involved in autism susceptibility include size and brain volume [Piven et al., 1996; 1999; Saitoh et al., 2001], and decreased [Bailey et al., 1998; Palmen et al., 2004].
technology, mouse geneticists are able to tion, a serious drawback of this approach consistent with the allele present in the associated alleles for a given disorder, and ways thought to be altered in autism.
more frequently in males than in females, investigated when evaluating the validity used to identify various candidate genes, mon allele found in fragile X patients is basis for Rett disorder; [Shibayama et al., 10% (e.g., Barton and Volkmar [1998]).
fragile X, the number of these repeats is modification is to generate a null allele, the deficits observed in the disease, but AMERICAN JOURNAL OF MEDICAL GENETICS PART C (SEMIN. MED. GENET.): DOI 10.1002/ajmg.c TABLE I. Genes Linked to Autism and the Relevant Mouse Models Genes for neurodevelopmental disorders associated with autism Nf1-null, heterozygous, and NF123aÀ/À mouse Other genes that may contribute to autism susceptibility Wnt2-null mouseDvl1 (Dishevelled-1)-null mouse Chiurazzi, 2001; Darnell et al., 2005].
also Paradee et al., 1999]. These differ- human disorders associated with autism.
late complex behavioral phenotypes,even in a defined, single-locus disease.
also reflects symptoms associated withthe human disorder. The null mice sequence is likely similar: severe reduction are two global methods of transcriptional attributed, in part, to the effect of the mice. In particular, the Fmr1-null allele AMERICAN JOURNAL OF MEDICAL GENETICS PART C (SEMIN. MED. GENET.): DOI 10.1002/ajmg.c truncation often leads to a classical Rett cations are associated with the preserved of the Mecp2 locus can lead to deficits in social interaction [Moretti et al., 2005].
and enhanced susceptibility for seizures, of the mutation [Jiang et al., 1998; Miura (NF1), an autosomal dominant disordercharacterized by cognitive and language deficits, poor motor skills, and tumors of the peripheral nerves [Silva et al., 1997; testing of heterozygotes has revealed that tion for tumors [Silva et al., 1997; Costa origin), the phenotype of these deletions [Chen et al., 2001; Guy et al., 2001].
targeted disruption have delayed onset of terol biosynthesis, suggesting a possible in mice leads to severe respiratory failure protein’s role in the disease process can [Fitzky et al., 2001; Wassif et al., 2001; neural tissue, rather than in the periph- ery. Another allele, Mecp2308, is similar tuberous sclerosis 1, is characterized by AMERICAN JOURNAL OF MEDICAL GENETICS PART C (SEMIN. MED. GENET.): DOI 10.1002/ajmg.c region of human chromosome 7p14.2-15. A polymorphism changing a histi- susceptibility for autism [e.g., Collabo- the population [Ingram et al., 2000].
rative Linkage Study of Autism, 1999].
allele for Sert is placed on a 129S6 strain cal signal transduction cascade, utilizing screened for autistic-like behaviors [see a premise supported by the identification for the null allele for Maoa have increased with elevated levels of serotonin in blood trations in the brain [Cases et al., 1995].
Pups exhibit trembling, difficulty right- and Leventhal, 1996]. Clinical trials have Wassink et al., 2001]. A null allele of the conditioned fear task [Kim et al., 1997], test [Popova et al., 2000]. Overall, Sert- significant behavioral effects of altera- interaction deficits [Lijam et al., 1997; ses in brain serotonin levels [Bengel et al., et al., 2004]. A targeted disruption of the foliation of the cerebellum [Joyner et al., Reeler brains revealed that neurons failed AMERICAN JOURNAL OF MEDICAL GENETICS PART C (SEMIN. MED. GENET.): DOI 10.1002/ajmg.c wire cage, which allows visual, auditory, association is not observed in all autism tions. An identical wire cage is placed in [Rodier, 1996; Insel, 2001; Murcia et al., symptoms characteristic of the ASDs.
clinicians, therapists, and other profes- ding schizophrenia, bipolar disorder, and sionals working in the field of autism, has depression, as well as with lissencephaly [Fatemi, 2001], suggesting that the Reeler to model specific aspects of autistic-like and in males and females [Brodkin et al., brain alterations specific to autism. Apart preference for social novelty. In this case, preference for social novelty, and learn- the unfamiliar mouse from the first phase maze task [Salinger et al., 2003; Lalonde et al., 2004]. Some studies have reported the opposite side of the test box. We have tasks that may be relevant to elements of demonstrate a shift in preference, so that stranger 2, rather than the more-familiar between two unfamiliar conspecifics.
nent for our behavioral testing battery.
avoidance, using a relatively rapid, auto- mated task [Nadler et al., 2004]. Further utilize observations of social interaction resident-intruder paradigm, or tube tests gene-dosage relationship [Salinger et al., titative evaluation of social approach and the first phase of this test, mice are given ses to social isolation early in develop- AMERICAN JOURNAL OF MEDICAL GENETICS PART C (SEMIN. MED. GENET.): DOI 10.1002/ajmg.c TABLE II. Mouse Behavioral Tasks for Modeling the Autism Phenotype Lijam et al. [1997]; Moretti et al. [2005] Mohn et al. [1999]; Moretti et al. [2005] Holtzman et al. [1996]; Moles et al. [2004] Restricted interests, repetitive behavior; Wu and Melton [1993]; Presti et al. [2003] DeLorey et al. [1998]; Turner et al. [2001] Salinger et al. [2003]; Yan et al. [2004] Griebel et al. [2000]; Ren-Patterson et al. [2005] Bouwknecht and Paylor [2002]; Peier et al. [2000] Tuetling et al. [1999]; Nielson et al. [2002] Martinez-Cue et al. [1999]; Long et al. [2004] Lalonde et al. [2004]; Moretti et al. [2005] Gerlai et al. [1996]; Miura et al. [2002] Morris water maze, hidden platform task Sago et al. [1998]; Lalonde et al. [2004]Radial arm maze Driscoll et al. [2004]; Frankland et al. [2004] DeLorey et al. [1998]; Lira et al. [2003] escape platform before a final probe trial.
rewards. One disadvantage of this task is perseverative sniffing, circling, digging, testing, the escape platform is placed in of motivational levels across strains.
ing [Cases et al., 1995; Homanics et al., grooming and scratching can lead to self- injury, such as torn ears and skin lesions tion during reversal learning could serve vior include measures of exploration on a during the reversal phase [Bakker et al., in an excessive adherence to routine.
pokes into a restricted set of holes, versus Bell et al., 2003], and the investigation of resistance to change a learned pattern of behavior. In this task, mice are trained to locate a hidden escape platform, which is particular arm (left or right) of the maze periphery of the pool. Spatial learning in AMERICAN JOURNAL OF MEDICAL GENETICS PART C (SEMIN. MED. GENET.): DOI 10.1002/ajmg.c can result in a less severe phenotype.
global view of the etiology of autism.
be changed in mouse models for ASDs.
trol measures, such as tests for activity vasopressin deficient mice [Insel et al., crucial for the interpretation of observed deficits in social preference [Moy et al., and paternal, present in the genome.
2004], as well as other tasks relevant to the appropriate parent [e.g., Jiang et al., 1998; Miura et al., 2002; Liljelund et al., appears to underlie susceptibility for the described in this review involve targeted across background strains, as observed in the Engrailed mouse, Joyner et al., 1991; disadvantage of this approach is that the consider strain characteristics when gen- for detailed genetic characterization.
characterized by reduction or loss of the candidate genes are not null alleles.
et al., 1999; Wahlsten et al., 2001].
alterations in the structure of the result- ing proteins, affect the amount of protein produced, or protein stability within the tory, 2002]. Intrinsic alterations in brain Alberi L, Sgado P, Simon HH. 2004. Engrailed genes are cell-autonomously required toprevent apoptosis in mesencephalic dopa- chromosome is inactivated, or silenced.
minergic neurons. Development 131:3229– AMERICAN JOURNAL OF MEDICAL GENETICS PART C (SEMIN. MED. GENET.): DOI 10.1002/ajmg.c American Psychiatric Association. 1994. Diag- Fang Y, Song C-Y, Vitale R. 2002. Associa- specific learning impairment. Neurosci 100: autism. Mol Psychiatry 7: 311–316.
Driscoll LL, Carroll JC, Moon J, Crnic LS, Amir RE, Van den Veyver IB, Wan M, Tran CQ, Cases O, Seif I, Grimsby J, Gaspar P, Chen K, binding protein 2. Nat Genet 23:185–188.
Alzheimer’s disease. Behav Neurosci 118: Anderson GM, Horne WC, Chatterjee D, Cohen lacking MAOA. Science 268:1763–1766.
Chen L, Toth M. 2001. Fragile X mice develop Duncan GE, Moy SS, Perez A, Eddy DM, Zinow sensory hyperreactivity to auditory stimuli.
Aylward EH, Minshew NJ, Goldstein G, Honey- BH. 2004. Deficits in sensorimotor gating Chen RZ, Akbarian S, Tudor M, Jaenisch R.
and tests of social behavior in a genetic protein-2 in CNS neurons results in a Rett- tion. Behav Brain Res 153:507–518.
retarded autistic adolescents and adults.
like phenotype in mice. Nat Genet 27:327– Falconer DS. 1951. Two new mutants. J Genet 50: Bailey A, Luthert P, Dean A, Harding B, Janota I, Cohen IL, Liu X, Schutz C, White BN, Jenkins Fatemi SH. 2001. Reelin mutations in mouse and Montgomery M, Rutter M, Lantos P. 1998.
A clinicopathological study of autism. Brain ciation of autism severity with a monoamine mood disorders, autism and lissencephaly.
Bakker CE, Verheij C, Willemsen R, van der Fatemi SH. 2005. Reelin glycoprotein: Structure, Collaborative Linkage Study of Autism. 1999. An biology and roles in health and disease. Mol autosomal genomic screen for autism. Am J Fatemi SH, Realmuto GM, Khan L, Thuras P.
Comery TA, Harris JB, Willems PJ, Oostra BA, cent patients with autism: A longitudinal knockout mice: A model to study fragile X Irwin SA, Weiler IJ, Greenough WT. 1997.
open trial. J Aut Dev Disorders 28:303– mental retardation. Cell 78:23–33.
Balogh SA, McDowell CS, Stavnezer AJ, Denen- Fisch GS, Hao HK, Bakker C, Oostra BA. 1999.
deficits. Proc Natl Acad Sci 94:5401–5404.
natomical assessment of an inbred substrain Conroy J, Meally E, Kearney G, Fitzgerald M, Gill of 129 mice with behavioral comparisons to M, Gallagher L. 2004. Serotonin transporter C57BL/6J mice. Brain Res 836:38–48.
gene and autism: A haplotype analysis in an Fitzky BU, Witsch-Baumgartner M, Erdel M, Lee Baranek GT. 2002. Efficacy of sensory and motor Irish autistic population. Mol Psychiatry interventions for children with autism. J Moebius FF. 1998. Mutations in the 7-sterol Cook EH, Leventhal BL. 1996. The serotonin sys- reductase gene in patients with the Smith- Barton M, Volkmar F. 1998. How commonly are tem in autism. Curr Opin Pediatr 8:348– Fitzky BU, Moebius FF, Asaoka H, Waage-Baudet Bell K, Shokrian D, Potenzieri C, Whitaker- Viskochil DH, Silva AJ, Brannan CI. 2001.
Learning deficits, but normal development ety, and response to novelty in the adoles- and tumor predisposition, in mice lacking exon 23a of Nf1. Nat Genet 27:399–405.
Glossmann H, Patel SB, Tint GS. 2001.
serotonin and relevance to Down syndrome.
Costa RM, Federov NB, Kogan JH, Murphy GG, 7-dehydrocholesterol-dependent proteolysis Neuropsychopharmacol 28:1810–1816.
Stern J, Ohno M, Kucherlapati R, Jacks T, Silva AJ. 2002. Mechanism for the learning biosynthesis in a mouse model of Smith– deficits in a mouse model of neurofibroma- Lemli–Opitz/RSH syndrome. J Clin Invest Westphal H, Lesch KP. 1998. Altered brain serotonin homeostasis and locomotor insen- Courchesne E, Karns CM, Davis HR, Ziccardi R, Folstein SE, Rosen-Sheidley B. 2001. Genetics of sitivity to 3,4-methylenedioxymethampheta- mine (‘‘Ecstasy’’) in serotonin transporter- P, Pierce K, Lord C, Lincoln AJ, Pizzo S, deficient mice. Mol Pharmacol 53:649–655.
Bodfish JW, Symons FJ, Parker DE, Lewis M.
Fombonne E. 2002. Epidemiological trends in 2000. Varieties of repetitive behavior in growth patterns in early life in patients with rates of autism. Mol Psychiatry 7:S4–S6.
autism: Comparisons to mental retardation.
autistic disorder. An MRI study. Neurology Frankland PW, Wang Y, Rosner B, Shimizu T, Bonora E, Beyer KS, Lamb JA, Parr JR, Klauck Darnell JC, Fraser CE, Mostovetsky O, Stefani G, AJ. 2004. Sensorimotor gating abnormalities Jones TA, Eddy SR, Darnell RB. 2005.
in young males with fragile X syndrome and Ragoussis I, Poustka A, Bailey AJ, Monaco AP, International Molecular Genetic Study Gerlai R, Millen KJ, Herrup K, Fabien K, Joyner reelin as a candidate gene for autism. Mol AL, Roder J. 1996. Impaired motor learning DeLorey TM, Handforth A, Anagnostaras SG, Bouwknecht JA, Paylor R. 2002. Behavioral and physiological mouse assays for anxiety: A Gharani N, Benayed R, Mancuso V, Brzustowicz survey in nine mouse strains. Behav Brain LM, Millonig JH. 2004. Association of the Brodkin ES, Hagemann A, Nemetski SM, Silver LM. 2004. Social approach-avoidance beha- vior of inbred mouse strains towards DBA/2 Gillberg C, Billstedt E. 2000. Autism and Asperger syndrome: Coexistence with other Buxbaum JD, Silverman JM, Smith CJ, Greenberg clinical disorders. Acta Psychiatr Scand 102: DA, Kilifarski M, Reichert J, Cook EH Jr, AMERICAN JOURNAL OF MEDICAL GENETICS PART C (SEMIN. MED. GENET.): DOI 10.1002/ajmg.c Gingrich JA, Hen R. 2001. Dissecting the role of Insel TR, O’Brien DJ, Leckman JF. 1999.
Liu WS, Pesold C, Rodriguez MA, Carboni G, Oxytocin, vasopressin, and autism: Is there disorders using knockout mice. Psychophar- a connection? Biol Psychiatry 45:145–157.
Jiang Y, Armstrong D, Albrecht U, Atkins CM, tion of dendritic spine and glutamic acid Griebel G, Belzung C, Perrault G, Sanger DJ.
Noebels JL, Eichele G, Sweatt JD, Beaudet decarboxylase 67 expressions in the reelin 2000. Differences in anxiety-related beha- haploinsufficient heterozygous reeler mouse.
ubiquitin ligase in mice causes increased inbred and outbred strains of mice. Psycho- cytoplasmic p53 and deficits of contextual Liu W, Pappas GD, Carter CS. 2005. Oxytocin learning and long-term potentiation. Neu- Guy J, Hendrich B, Holmes M, Martin JE, Bird reduced in haploinsufficient (þ/À) reeler Joyner AL, Herrup K, Auerbach BA, Davis CA, Rossant J. 1991. Subtle cerebellar pheno- Long JM, LaPorte P, Paylor R, Wynshaw-Boris A.
Rett syndrome. Nat Genet 27:322–326.
Hagerman RJ, Jackson AWIII, Levitas A, Rim- lacking Dvl1. Genes Brain Behav 3:51–62.
Keller F, Persico AM. 2003. The neurobiological syndrome. Am J Med Genet 23:359–374.
context of autism. Mol Neurobiol 28:1–22.
Happe´ F, Ehlers S, Fletcher P, Frith U, Johansson M, Kim JJ, Shih JC, Chen K, Chen L, Bao S, Maren 1.6 homeobox gene results in defects in a Gillberg C, Dolan R, Frackowiak R, Frith C.
region corresponding to its rostral domain of 1996. ‘‘Theoryof mind’’ inthebrain. Evidence from a PET scan study of Asperger syndrome.
Martinez-Cue C, Baamonde C, Lumbreras MA, learning in monoamine oxidase A-deficient Vallina IF, Dierssen M, Florez J. 1999. A Hodge RD, D’Ercole AJ, O’Kusky JR. 2005.
mice. Proc Natl Acad Sci 94:5929–5933.
Increased expression of insulin-like growth Kim S-J, Cox N, Courchesne R, Lord C, Corsello factor-I (IGF-I) during embryonic develop- ment produces neocortical overgrowth with Mineur YS, Sluyter F, de Wit S, Oostra BA, Crusio differentially greater effects on specific sion disequilibrium mapping at the seroto- cytoarchitectonic areas and cortical layers.
autistic disorder. Mol Psychiatry 7:278–288.
Hollander E, Phillips A, Chaplin W, Zagursky K, Kooy RF, D’Hooge R, Reyniers E, Bakker CE, Miura K, Kishino T, Li E, Webber H, Dikkes P, Novotny S, Wasserman S, Iyengar R. 2005.
A placebo controlled crossover trial of liquid G, De Deyn PP, Oostra BA, Willems PJ.
vioral and electroencephalographic abnor- fluoxetine on repetitive behaviors in child- malities in Ube3a maternal-deficient mice.
Mohn AR, Gainetdinov RR, Caron MG, Koller Holmes A, Yang RJ, Murphy DL, Crawley JN.
Kremer EJ, Pritchard M, Lynch M, Yu S, Holman 2002. Evaluation of antidepressant-related receptor expression display behaviors related to schizophrenia. Cell 98:427–436.
ping of DNA instability at the fragile X to a Moles A, Kieffer BL, D’Amato F. 2004. Deficit trinucleotide repeat sequence p(CCG)n.
in attachment behavior in mice lacking the Holmes A, Li Q, Murphy DL, Gold E, Crawley m-opioid receptor gene. Science 304:1983– Lalonde R, Hayzoun K, Derer M, Mariani J, vior in serotonin transporter null mutant Strazielle C. 2004. Neurobehavioral evalua- Monkley SJ, Delaney SJ, Pennisi DJ, Christiansen mice: The influence of genetic background.
tion of Relnrl-orl mutant mice and correla- JH, Wainwright BJ. 1996. Targeted disrup- tions with cytochrome oxidase activity.
tion of the Wnt2 gene results in placentation Holtzman DM, Santucci D, Kilbridge J, Chua- defects. Development 122:3343–3353.
Couzens J, Fontana DJ, Daniels SE, Johnson Larson J, Hoffman JS, Guidotti A, Costa E. 2003.
Moretti P, Bouwknecht JA, Teague R, Paylor R, Olfactory discrimination learning deficit in mental abnormalities and age-related neu- Lijam N, Paylor R, McDonald MP, Crawley JN, Moy SS, Nadler JJ, Perez A, Barbaro RP, Johns JM, Magnuson TR, Piven J, Crawley JN.
2004. Sociability and preference for social sensorimotor gating abnormalities in mice novelty in five inbred strains: An approach to assess autistic-like behavior in mice. Genes Liljelund P, Handforth A, Homanics GE, Olsen Ferguson C, Synder K, Olsen RW. 1997.
parent-of-origin and gender-related differ- palate, and hypersensitive behavior. Proc behavior. Dev Brain Res 157:150–161.
Muris P, Steerneman P, Merckelbach H, Holdri- Lim MM, Bielsky IF, Young LJ. 2005. Neuropep- net I, Meesters C. 1998. Comorbid anxiety tides and the social brain: Potential rodent symptoms in children with pervasive devel- models of autism. Int J Devl Neurosci 23: opmental disorders. J Anxiety Dis 12:387– Ingram JL, Stodgell CJ, Hyman SL, Figlewicz DA, Nadler JJ, Moy SS, Dold G, Trang D, Simmons N, HF, Hofer MA, Hen R, Gingrich JA. 2003.
apparatus for rapid quantitation of autism- spectrum disorders. Teratology 62:393–405.
like social deficits in mice. Genes Brain Insel TR. 2001. Mouse models for autism: Report nucleus of serotonin transporter-deficient Turner BM, Eisenman RN, Bird A. 1998.
AMERICAN JOURNAL OF MEDICAL GENETICS PART C (SEMIN. MED. GENET.): DOI 10.1002/ajmg.c Transcriptional repression by the methyl- Risch N, Spiker D, Lotspeich L, Nouri N, Hinds D, Hallmayer J, Kalaydjieva L, McCague P, Skaar DA, Shao Y, Haines JL, Stenger JE, Jaworski Nielson DM, Derber WJ, McClellan DA, Crnic McCauley JL, Sutcliffe JS, Ashley-Koch AE, LS. 2002. Alterations in the auditory startle Nicholas P, Petersen PB, Pingree C, McMa- autism. Mol Psychiatry 10:563–571.
North K. 2000. Neurofibromatosis type 1. Am J screen of autism: Evidence for a multilocus Spencer CM, Alekseyenko O, Serysheva E, Yuva- etiology. Am J Hum Genet 65:493–507.
Paylor LA, Paylor R. 2005. Altered anxiety- Nurmi EL, Bradford Y, Chen Y, Hall J, Arnone B, Rodier PM. 1996. Animal model of autism based drome. Genes Brain Behav 4(7):420–430.
Rodriguiz RA, Chu R, Caron MG, Wetsel WC.
The Jackson Laboratory. 2002. Genetic background 2004. Aberrant responses in social interac- effects: Can your mice see? JAX/Notes 485:2.
Tuetling P, Costa E, Dwivedi Y, Guidotti A, mice. Behav Brain Res 148:185–198.
Impagnatiello F, Manev R, Pesold C. 1999.
Rosso SB, Sussman D, Wynshaw-Boris A, Salinas The phenotypic characteristics of hetero- Oostra BA, Chiurazzi P. 2001. The fragile X gene and its function. Clin Genet 60:399–408.
development. Nat Neurosci 8:34–42.
Turner CA, Presti MF, Newman HA, Bugenha- Palmen SJMC, van Engeland H, Hof PR, Schmitz Sago H, Carlson EJ, Smith DJ, Kilbridge J, Rubin EM, Mobley WC, Epstein CJ, Huang T-T.
Paradee W, Melikian HE, Rasmussen DL, Ken- neson A, Conn PJ, Warren ST. 1999. Fragile ing and behavioral abnormalities. Proc Natl Vincent JP, Lawrence PA. 1994. Drosophila wingless sustains engrailed expression only Saitoh O, Karns CM, Courchesne E. 2001.
amygdala function. Neuroscience 94:185– from 2 to 42 years: MRI evidence of smaller Wagstaff J, Knoll JHM, Fleming J, Kirkness EF, Peier AM, McIlwain KL, Kenneson A, Warren area dentata in autism. Brain 124:1317– Salinger WL, Ladrow P, Wheeler C. 2003.
Lalande M. 1991. Localization of the gene transgenics: Behavioral and physical features.
Behavioral phenotype of the reeler mutant mouse: Effects of Reln gene dosage and social Persico AM, D’Agruma L, Maiorano N, Totaro A, isolation. Behav Neurosci 117:1257–1275.
Militerni R, Bravaccio C, Wassink TH, for Samaco RC, Hogart A, LaSalle JM. 2005.
Epigenetic overlap in autism-spectrum neu- Wahlsten D, Crabbe JC, Dudek BC. 2001. Beha- vioural testing of standard inbred and 5HT1B Puglisi-Allegra S, Reichelt K-L, Conciatori ciency causes reduced expression of UBE3A knockout mice: Implications of absent corpus callosum. Behav Brain Res 125:23–32.
Zelante L, Gasparini P, Keller F. 2001.
Wan M, Lee SSJ, Zhang X, Houwink-Manville I, Schultz RT, Gauthier I, Klin A, Fulbright RK, factor predisposing to autistic disorder. Mol Piven J, Arndt S, Bailey J, Andreasen N. 1996.
Abnormal ventral temporal cortical activity beyond: Recurrent spontaneous and familial duals with autism and Asperger syndrome.
Battaile KP, Weight FF, Grinberg A, Steiner Piven J, Bailey J, Ranson BJ, Arndt S. 1997. An MRI study of the corpus callosum in autism.
and neurophysiological characterization of a Popova NK, Vishnivetskaya GB, Ivanova EA, Skrinskaya JA, Seif I. 2000. Altered behavior display hyperacetylation of histone H3.
Shibayama A, Cook EHJr, Feng J, Glanzmann C, Wassink TH, Piven J, Vieland VJ, Huang J, Swiderski RE, Pietila J, Braun T, Beck G, Folstein SE, Haines JL, Sheffield VC. 2001.
Presti MF, Watson CJ, Kennedy RT, Yang M, structural and 3’-UTR variants in schizo- phrenia, autism and other psychiatric dis- tions of striatal neurochemistry in a mouse eases: A possible association with autism.
model of stereotyped movement disorder.
Williams CA. 2005. Neurological aspects of the Silva AJ, Frankland PW, Marowitz Z, Friedman E, Angelman syndrome. Brain Dev 27:88–94.
Lazlo G, Cioffi D, Jacks T, Bourtchuladze R.
Wilson C, Idziaszczyk S, Parry L, Guy C, Griffiths Sherrill S, Huang S-J, Tolliver T, Lesch K- specific early post-natal mortality and meta- Simon HH, Scholz C, O’Leary DD. 2005.
static renal cell carcinoma. Hum Mol Genet and increases stress abnormalities of seroto- Engrailed genes control developmental fate nin transporter knockout mice. J Neurosci of serotonergic and noradrenergic neurons AMERICAN JOURNAL OF MEDICAL GENETICS PART C (SEMIN. MED. GENET.): DOI 10.1002/ajmg.c hypoxanthine phosphoribosyltransferase-de- Yu H, Wessels A, Tint GS, Patel SB. 2005. Partial of the Rett syndrome: Molecular and clinical ficient mice. Nat Genet 3:235–239.
rescue of neonatal lethality of Dhcr7 null analysis. Am J Med Genet 104:14–22.
Zhuang X, Gross C, Santarelli L, Compan V, tional states in knockout mice lacking 5- Renieri A. 2001. Preserved speech variants


October 2006 Editorial Olivier Forcade, president of the Academic Council and the Board of Administrators of the EFEO for the past four years, has recently been elected to the Chair of Contemporary History at Amiens University. He is leaving his responsibilities for the French Institutes Abroad at the Ministry of Higher Education and Research. The EFEO is deeply indebted to Mr. Forcade,


Projektliste "Junior Research Group" (JRG) Environmental Archaeology, Wiebke Kirleis Bezeichnung/Ort Zeitstellung Zuständige Person/en Kooperation Mittel- und NordeuropaTrauerfloristik herzöglicher Kirchengrüfte in Wiebke Kirleis, Ulrich Müller, Helmut KrollDr. Regina Ströbl, LDA Mecklenburg-Vorpommern, SchwerinDr. Andreas Stroebl, AG Friedhof und Denkmal e.V., Zentr

Copyright © 2010-2014 Pharmacy Pills Pdf